Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases

Details for Australian Patent Application No. 2006212022 (hide)

Owner Pulmagen Therapeutics (Synergy) Limited

Inventors Fitzgerald, Mary Frances; Finch, Harry; Fox, Justian Craig

Agent Davies Collison Cave

Pub. Number AU-B-2006212022

PCT Pub. Number WO2006/085102

Priority 0526124.3 22.12.05 GB; 0502949.1 11.02.05 GB

Filing date 13 February 2006

Wipo publication date 17 August 2006

Acceptance publication date 3 February 2011

International Classifications

A61K 31/52 (2006.01)

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/085102 Priority application(s): WO2006/085102

12 August 2010 Alteration of Name

  The name of the applicant has been altered to Pulmagen Therapeutics (Synergy) Limited

3 February 2011 Application Accepted

  Published as AU-B-2006212022

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006212024-Method for isolating nucleic acids comprising the use of ethylene glycol multimers

2006212021-Pharmaceutical compositions useful in the transmucosal administration of drugs